Using a multi-shunt-based current-monitoring circuit with a 50-MHz op amp delivers an overcurrent detection response time of ...

Pierre Gholam, MD, observes the improvements in outcomes with lenvatinib seen in recent trials of unresectable hepatocellular carcinoma compared with the original phase 3 REFLECT trial.

Apple's new iPhone 17 models are proving to be more popular than their predecessors over the first pre-order weekend, both in ...

To the extent there is a lesson, it is this: once you hedge out currency risk, each currency operates as its own separated ...

Both Novo Nordisk and Eli Lilly are eyeing regulatory advancements for their obesity blockbusters as the European Association ...

As a strike looms, teachers say they are underpaid for the growing workload they bear, and burning out from trying to meet ...

Exelixis (EXEL) stock wins a Buy at Goldman Sachs based on potential of its lead asset, zanzalintinib, ahead of a patent ...

Derbyshire County Council’s leader has told how the authority is facing ‘hard choices’ and having to consider job cuts to get what he believes is an over-staffed council running more efficiently for ...

Hispanic patients starting hemodialysis in the US are less likely to receive predialysis nephrology care and, consequently, ...

NCWNZ, alongside Rangahau Aotearoa Research New Zealand, has been monitoring attitudes to gender in Aotearoa New Zealand ...

As per secondary analysis, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which ...

Women with systemic sclerosis face increased risks for APOs, with certain risks being elevated even before diagnosis.